2509 — Qyuns Therapeutics Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for Qyuns Therapeutics Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	620	614	377	556	1,042
Net Total Receivables	8.65	4.04	10.6	26.9	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	648	636	418	617	1,117
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	406	389	363	334	310
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,067	1,035	796	984	1,600
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	69.7	122	252	430	504
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	397	393	501	755	906
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	670	642	295	229	694
Total Liabilities & Shareholders' Equity	1,067	1,035	796	984	1,600
Total Common Shares Outstanding